Abstract
Stent thrombosis (ST) is an infrequent event following 2nd generation drug-eluting stents (DES); however, its occurrence may be catastrophic. Our objective was to report the incidence of ST in a large population treated with Endeavor zotarolimus-eluting stents (E-ZES) and randomized to short- (3
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
